Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity

*Department of Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, the Netherlands;

†Department of Clinical Pharmacy, Deventer Hospital, Deventer, the Netherlands;

‡Department of Pharmacy, Radboud Institute of Health Sciences, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands;

§Unit of Pharmacotherapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, the Netherlands;

¶Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands;

‖Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; and

**Department of Pharmacy, Academic Medical Centre, Amsterdam, the Netherlands.

Correspondence: Suzan E. H. Detert Oude Weme, PharmD, MSc, Department of Clinical Pharmacy, Deventer Teaching Hospital, Nico Bolkesteinlaan 75, 7416 SE Deventer, the Netherlands (e-mail: [email protected]).

The authors declare no conflict of interest.

R. H. L. Hoge and S. E. H. Detert Oude Weme shares (co-)first authorship.

The study was conducted in accordance with the Declaration of Helsinki.

The data that support the findings of this study are available from the corresponding author on reasonable request.

留言 (0)

沒有登入
gif